DrugCite
Search

PANTECTA

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Pantecta Adverse Events Reported to the FDA Over Time

How are Pantecta adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Pantecta, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Pantecta is flagged as the suspect drug causing the adverse event.

Most Common Pantecta Adverse Events Reported to the FDA

What are the most common Pantecta adverse events reported to the FDA?

Death
24 (13.48%)
Dizziness
6 (3.37%)
Gastrointestinal Haemorrhage
6 (3.37%)
Cerebral Infarction
5 (2.81%)
Transient Ischaemic Attack
5 (2.81%)
Asthenia
4 (2.25%)
Wheezing
4 (2.25%)
Acute Pulmonary Oedema
3 (1.69%)
Cardiac Failure
3 (1.69%)
Chest Discomfort
3 (1.69%)
Fall
3 (1.69%)
Show More Show More
Osteoporosis
3 (1.69%)
Renal Failure
3 (1.69%)
Renal Failure Chronic
3 (1.69%)
Rib Fracture
3 (1.69%)
Anaemia
2 (1.12%)
Arthralgia
2 (1.12%)
Bone Densitometry
2 (1.12%)
Breast Cancer
2 (1.12%)
Bronchospasm
2 (1.12%)
Colon Cancer
2 (1.12%)
Dengue Fever
2 (1.12%)
Diabetes Mellitus
2 (1.12%)
Drug Ineffective
2 (1.12%)
Gallbladder Cancer
2 (1.12%)
Gastritis
2 (1.12%)
Haemorrhage
2 (1.12%)
Hepatic Failure
2 (1.12%)
Hiatus Hernia
2 (1.12%)
Hypoglycaemia
2 (1.12%)
Impaired Healing
2 (1.12%)
Liver Disorder
2 (1.12%)
Metastasis
2 (1.12%)
Myocardial Infarction
2 (1.12%)
Neoplasm Malignant
2 (1.12%)
Neutropenia
2 (1.12%)
Penile Ulceration
2 (1.12%)
Rash
2 (1.12%)
Ulcer
2 (1.12%)
Urticaria
2 (1.12%)
Abdominal Mass
1 (.56%)
Abdominal Sepsis
1 (.56%)
Aggression
1 (.56%)
Agranulocytosis
1 (.56%)
Anastomotic Leak
1 (.56%)
Benign Pancreatic Neoplasm
1 (.56%)
Bronchitis Bacterial
1 (.56%)
Bronchopneumonia
1 (.56%)
Caesarean Section
1 (.56%)
Cardio-respiratory Arrest
1 (.56%)
Cerebrovascular Accident
1 (.56%)
Condition Aggravated
1 (.56%)
Dermatitis
1 (.56%)
Disorientation
1 (.56%)
Drug Exposure During Pregnancy
1 (.56%)
Dyspnoea
1 (.56%)
Endoscopy Upper Gastrointestinal Tr...
1 (.56%)
Gastric Cancer
1 (.56%)
Gastric Disorder
1 (.56%)
Gastric Operation
1 (.56%)
Haematocrit Decreased
1 (.56%)
Haemolytic Anaemia
1 (.56%)
Hand Fracture
1 (.56%)
Hepatic Encephalopathy
1 (.56%)
Hepatitis
1 (.56%)
Hernia Repair
1 (.56%)
Hip Fracture
1 (.56%)
Hyperbilirubinaemia
1 (.56%)
Immunosuppression
1 (.56%)
Influenza
1 (.56%)
International Normalised Ratio Incr...
1 (.56%)
Laryngeal Oedema
1 (.56%)
Leukocytosis
1 (.56%)
Lymphoma
1 (.56%)
Malaise
1 (.56%)
Metastases To Lung
1 (.56%)
Nausea
1 (.56%)
Oesophageal Disorder
1 (.56%)
Oesophageal Varices Haemorrhage
1 (.56%)
Osteitis
1 (.56%)
Ovarian Cancer
1 (.56%)
Ovarian Operation
1 (.56%)
Pain In Jaw
1 (.56%)
Pancreatic Carcinoma
1 (.56%)
Pancreatitis
1 (.56%)
Parotitis
1 (.56%)
Pharyngeal Oedema
1 (.56%)
Rash Generalised
1 (.56%)
Respiratory Distress
1 (.56%)
White Blood Cell Count Increased
1 (.56%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Pantecta, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Pantecta is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Pantecta

What are the most common Pantecta adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Pantecta, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Pantecta is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Pantecta According to Those Reporting Adverse Events

Why are people taking Pantecta, according to those reporting adverse events to the FDA?

Gastritis
14
Dyspepsia
8
Gastrooesophageal Reflux Disease
7
Prophylaxis
7
Duodenitis
5
Drug Use For Unknown Indication
4
Show More Show More
Rheumatoid Arthritis
2
Oesophageal Spasm
2
Product Used For Unknown Indication
2
Hepatic Cirrhosis
2
Peptic Ulcer
2
Gastrectomy
1
Upper Gastrointestinal Haemorrhage
1
Gastroduodenal Ulcer
1
Gastritis Prophylaxis
1
Hiatus Hernia
1
Gastric Ulcer
1
Steroid Therapy
1
Analgesic Intervention Supportive T...
1
Helicobacter Infection
1
Gastrointestinal Haemorrhage
1
Cholangitis
1
Vomiting
1
Abdominal Discomfort
1
Irritable Bowel Syndrome
1
Prophylaxis Against Gastrointestina...
1
Gastric Disorder
1
Colitis
1

Pantecta Case Reports

What Pantecta safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Pantecta. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Pantecta.